-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Halia Therapeutics- Targeting the Chronic Inflammatory Bone Marrow Microenvironment

Sponsor: Halia Therapeutics
Program: Company Showcases
Sunday, December 10, 2023: 4:00 PM-4:15 PM
Room 5B (San Diego Convention Center)
David Bearss, PhD, Halia Therapeutics and Alan List, MD, Halia Therapeutics
No relevant conflicts of interest to declare.
For In-Person Participants Only
See more of: Company Showcases